Related Experiment Video
Updated: Dec 10, 2025

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
The Interaction between Arachidonic Acid Metabolism and Homocysteine
Elisa Domi1, Malvina Hoxha1, Bianka Hoxha1
1Department of Chemical-Toxicological and Pharmacological Evaluation of Drugs, Faculty of Pharmacy, Catholic University Our Lady of Good Counsel, Rruga Dritan Hoxha, Tirana, Albania.
Insights
High homocysteine (HHcy) levels impact cardiovascular health and inflammation by altering arachidonic acid (AA) metabolism. Targeting HHcy in AA pathways may lead to new treatments and dietary interventions.
Area of Science:
- Biochemistry
- Cardiovascular Science
- Metabolic Research
Background:
- Hyperhomocysteinemia (HHcy) is a known risk factor for cardiovascular disease (CVD), inflammation, and neurological disorders.
- Arachidonic acid (AA) metabolism plays a critical role in vascular homeostasis and inflammatory processes, with imbalances linked to CVD development.
Purpose of the Study:
- To review the influence of homocysteine (Hcy) on arachidonic acid (AA) metabolism.
- To explore potential therapeutic and dietary strategies targeting the interplay between Hcy and AA pathways.
Main Methods:
- In silico literature searches were conducted using PubMed and Scopus.
- Analysis of existing studies detailing the relationship between Hcy levels and AA metabolite synthesis and activity.
Main Results:
- Altered Hcy levels affect AA release and metabolism.
- Hcy influences the synthesis and activity of key AA metabolites, including prostaglandins (PGs), prostacyclin (PGI2), thromboxane (TXA), epoxyeicosatrienoic acids (EETs), and hydroxyeicosatetraenoic acids (HETEs).
Conclusions:
- Modulating Hcy within AA pathways offers potential for developing novel therapeutic compounds with improved pharmacological benefits.
- Understanding this interaction is valuable for dietitians in developing dietary strategies to enhance health.
Abstract:
Hyperhomocysteinemia (HHcy) has been considered a risk factor for different diseases, including cardiovascular disease (CVD), inflammation, neurological diseases, cancer, and many other pathological conditions. Likewise, arachidonic acid (AA) metabolism is implicated in both vascular homeostasis and inflammation, as shown by the development of CVD, following the imbalance of its metabolites. This review summarizes how homocysteine (Hcy) can influence the metabolism of AA. In silico literature searches were performed on PubMed and Scopus as main sources. Several studies have shown that altered levels of Hcy, through AA release and metabolism, can influence the synthesis and the activity of prostaglandins (PGs), prostacyclin (PGI2), thromboxane (TXA), epoxyeicosatrienoic acids (EETs), and hydroxyeicosatetraenoic acids (HETEs). It is believed that by targeting Hcy in the AA pathways, novel compounds with better pharmacological and pharmacodynamics benefits may be obtained and that this information is valuable for a dietician to manipulate diets to improve health.
More Related Videos
09:26Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
Published on: November 17, 2011
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Related Concept Videos
Sulfur Assimilation
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Drug Metabolism: Phase II Reactions
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Amino Acid Biosynthetic Pathways
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...